BCTX

BriaCell Therapeutics Corp · NASDAQ

Sector Health Technology
Industry Biotechnology
Website briacell.com
Employees(FY) 16
ISIN CA1079301091

Performance

+4.15%

1W

-16.91%

1M

-42.57%

3M

-46.45%

6M

-61.37%

YTD

-68.4%

1Y

Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Advanced Technical Analysis

Technical Analysis of BCTX 2024-05-03

Overview:

In analyzing the technical indicators for BCTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

...

See more ...

Recent News & Updates

2024-04-23 20:00
BriaCell Announces Oral and Poster Presentations at ASCO 2024(Globenewswire)
2024-04-09 20:00
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+ and Bria-PROS+ Clinical Candidates for Breast and Prostate Cancer(Globenewswire)
2024-04-08 20:00
BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR(Globenewswire)
2024-03-18 18:52
BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024(Investorplace)
2024-03-06 19:00
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies(Globenewswire)
2024-03-05 19:00
BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference(Globenewswire)
2024-02-26 19:00
BriaCell Provides Update on Alleged Illegal Trading of Public Securities(Globenewswire)
2024-02-06 19:00
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case(Globenewswire)
2024-02-05 19:30
Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing(Globenewswire)
2024-01-30 09:48
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting(Globenewswire)
2024-01-03 19:45
BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with Eye-Bulging Metastatic Breast Cancer(Globenewswire)
2023-12-27 19:55
BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients(Globenewswire)
2023-12-19 19:40
BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset(Globenewswire)
2023-12-05 20:31
BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS(Globenewswire)
2023-12-05 20:00
BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit(Globenewswire)
2023-11-29 18:00
BriaCell Records New Responder with Remarkable Improvement of Eye-Bulging Metastatic Tumor(Globenewswire)
2023-11-02 20:31
BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS IND(Globenewswire)
2023-10-31 22:49
BCTX: Year in Review(Yahoo Finance)
2023-10-24 21:15
BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidate(Globenewswire)
2023-10-19 21:15
October is Breast Cancer Awareness Month BriaCell is Leading the Fight with its Innovative Technology(Globenewswire)
2023-10-17 21:00
BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences(Globenewswire)
2023-10-10 21:10
BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinic(Globenewswire)
2023-10-03 21:00
BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT in Advanced Breast Cancer(Globenewswire)
2023-10-02 21:00
BriaCell Initiates Pivotal Phase 3 Study of Bria-IMT in Advanced Metastatic Breast Cancer(Globenewswire)
2023-09-07 19:00
BriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer(Yahoo Finance)
2023-08-30 23:54
BriaCell Therapeutics Corp. Announces Closing of Plan of Arrangement Spinning Out BriaPro Therapeutics Corp. to Existing Shareholders(Yahoo Finance)
2023-08-30 20:21
BriaCell Accepts Letter of Intent from Weill Cornell Medicine Outlining Plans to Initiate a Clinical Trial of Bria-IMT in High-Risk Early-Stage Triple Negative Breast Cancer(Yahoo Finance)
2023-08-25 02:33
BriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing Shareholders(Yahoo Finance)
2023-08-18 00:21
BriaCell Therapeutics Corp. Announces Voting Results From Special Meeting(Yahoo Finance)
2023-08-15 20:36
BriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS Immunotherapy for Cancer(Yahoo Finance)

Page 1 of 4

previousnext